You are here: Industry Insights > SARS-CoV-2

News List

An in vitro study shows Pfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with a mutation associated with rapid transmission worldpharmanews
January 11, 2021
Pfizer Inc. and BioNTech SE announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively ...
Trial to evaluate monoclonal antibody therapy for mild-to-moderate COVID-19 europeanpharmaceuticalreview
January 07, 2021
The study will determine if the combination of BRII-196 and BRII-198, two investigational antibodies for SARS-CoV-2, can prevent disease progression.
Seegene's COVID-19 test with saliva sample collection feature now available in Europe prnewswire
January 07, 2021
South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Tuesday that it has CE-IVD marked the saliva-based testing application for Allplex™ SARS-CoV-2 Assay and Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay ...
New virtual screening strategy identifies existing drug that inhibits COVID-19 virus worldpharmanews
January 04, 2021
A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19.
Sustained cellular immune dysregulation in individuals recovering from COVID-19 worldpharmanews
December 30, 2020
COVID-19, which has killed 1.7 million people worldwide, does not follow a uniform path.Many infected patients remain asymptomatic or have mild symptoms.
INEX Innovate's CORO(TM) Real-Time RT-PCR SARS-CoV-2 Kit for the detection of COVID-19 obtains Singapore's Health Sciences Authority Provisional Authorisation prnasia
December 30, 2020
INEX Innovate Pte Ltd a Singapore based molecular diagnostics developer announced that the Singapore Health Sciences Authority has issued provisional authorisation to the company's CORO™ Real-Time RT-PCR SARS-CoV-2 for the diagnosis of COVID-19.
Vaccines in pipeline will work against the new COVID-19 variants: Dr K Raghavan expresspharma
December 30, 2020
Committee of experts to soon give report on the process of identifying and prioritising patients with co-morbidities, for the purpose of vaccination: Dr VK Paul.
Study finds antibodies target different parts of SARS-CoV-2 in severe COVID-19 cases expresspharma
December 28, 2020
People with severe COVID-19 have lower levels of antibodies targeting the spike protein used by the virus to enter human cells than those targeting proteins of the inner shell of the SARS-CoV-2 virus.
BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens prnasia
December 23, 2020
BioVaxys Technology Corp. announced that further analysis of the data from a preclinical animal study (also known as the "murine model study") of its haptenized viral protein vaccine technology show that BVX-0320, its COVID-19 vaccine candidate based ...
How SARS-CoV-2 interacts with cells worldpharmanews
December 23, 2020
SARS-CoV-2 infections pose a global threat to human health and a formidable research challenge. One of the most urgent tasks is to gain a detailed understanding of the molecular interactions between the virus and the cells it infects.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page